A high expression of PDIA3 correlates with prognosis, immune regulators, immune cell infiltration, tumor microenvironment, TMB, and MSI in various cancers; hence, we believe that PDIA3 blocking may be an efficient and feasible therapy for cancers. This evidence concerns the gene PDIA3 and cancer.